Business Wire

Last Chance to Register for Official CES 2020 Preview Event in Paris

21.10.2019 09:00:00 EEST | Business Wire | Press release

Share

The Consumer Technology Association:

WHAT:

 

The Consumer Technology Association (CTA)® today announced the last chance to register for the seventh annual CES Unveiled in Paris. CES Unveiled in Paris is an official CES® 2020 preview event, bringing together executives, influential media and prominent industry influencers to experience the latest tech innovations from across Europe.

 

Europe welcomed more than 16,000 attendees to CES 2019 and continues to lead innovation by example. CES Unveiled promotes the continued value it shares with Europe through partnerships across government, business and research.

 

CES Unveiled in Paris will focus on the theme of artificial intelligence (AI), featuring exhibitors from France and across Europe. Some top exhibitors include:

 

  • Aitheon – Integrates artificial intelligence (AI) and Robotics in a user-friendly way to ensure businesses become automated in a single, simple platform
  • Coleen – Develops an electric bike for those whose technical performance is matched by its distinctive design
  • InnovHealth – Ensures people can possess all of their health data while taking into account the digital transformation of healthcare systems
  • Minelab – Provides metal detecting technologies for consumer, humanitarian demining and military needs
  • TransChain – Improves the B2B market by creating a digital trust between all professionals through blockchain
  • VOLUMIC 3D – Offers multi-material 3D printing, with a high level of precision, high reliability and the ability to print in large sizes

Attendees will have the opportunity to see and interact with the latest innovations in AI, enterprise solutions, health and wellness, IoT infrastructure, smart cities and more. Check the CES Unveiled in Paris website for the full exhibitor list.

 

WHO:

 

This year’s event will provide a conference track on AI. Announced speakers include:

  • Jean-Philippe Desbiolles, VP, Cognitive Solutions, IBM Watson
  • Isabelle Ryl, Professor, Director of PRAIRIE, INRIA
  • Laurence Lafont, Chief Operating Officer, Microsoft France
  • Edward Bouygues, Chief Strategy Officer, Bouygues Telecom
  • Aude Vinzerich, Head of AI, EDF
  • Sophie Proust, Chief Technology Officer, Atos
  • Anne-Laure Thieullent, Managing Director, AI & Analytics Group Offer Leader, CapGemini
  • Frédéric Vezon, Co-president and founder, ASPertise
  • Fabrice Tocco, Co-founder and Co-CEO, Dawex
  • Grégoire Ferré, Group VP, Digital Transformation and AI, Faurecia
  • Guive Balooch, Head of L’Oreal's Technology Incubator
  • Mathieu Colas, Senior Partner, Monitor Deloitte
  • Guillaume Devauchelle, Group Vice President Innovation & scientific development, Valeo
  • Natalie Cernecka, Head of Business Development, TeraLab
  • Valerie Hoffenberg, President and Founder, Connecting Leaders Club
  • Gary Shapiro, president and CEO, CTA
  • Karen Chupka, EVP, CES
  • Steve Koenig, VP of Market Research, CTA

Conference programming will open with a CES 2020 preview, which will highlight new industry trends and developments to be seen at CES 2020. Additional conference sessions will explore data sharing models in the mobility ecosystem, promoting diversity in AI and more. To see all speakers and the full event schedule, visit CES.tech.

 

WHEN:

 

CES Unveiled in Paris, France

Tuesday, October 22, 2019

13:00-20:00

Palais Brongniart, Paris, France

Register Now

*Press room (Napoléon) will open at 9:00

 

DETAILS:

 

CES Unveiled in Paris is held on Tuesday, Oct. 22 at Palais Brongniart. Attendees and media can register for the event online or on-site. For more information about exhibiting and showcasing your products and technology, please contact CESUnveiled@CTA.tech. To see the full event schedule, visit CES.tech.

About CES:

CES® is the largest, most influential tech event in the world – the proving ground for breakthrough technologies and global innovators. This is where the world's biggest brands do business and meet new partners, and the sharpest innovators hit the stage. Owned and produced by the Consumer Technology Association (CTA)®, CES features every aspect of the tech sector. Learn more at CES.tech and follow CES on social.

About Consumer Technology Association:

As North America’s largest technology trade association, CTA® is the tech sector. Our members are the world’s leading innovators – from startups to global brands – helping support more than 18 million American jobs. CTA owns and produces CES® – the largest, most influential tech event on the planet. Find us at CTA.tech. Follow us @CTAtech.

UPCOMING EVENTS

  • CES 2020
    January 7-10, 2020 – Las Vegas, NV

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Justin Siraj
703-907-7415
jsiraj@CTA.tech

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release

Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 17:13:00 EEST | Press release

For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and more practical: what it takes to make a specific, high-stakes determination reliable, fast and affordable at scale. A vertical, domain-focused process, gro

Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 17:08:00 EEST | Press release

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d

Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 17:00:00 EEST | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by market capitalization and is home to world-leading companies such as Samsung Electr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye